Establish a comprehensive national cancer control programme to protect Saudi society from cancer through shared responsibility, evidence-based prevention, early detection, integrated treatment and palliative care across primary, secondary and tertiary services.The programme responds to cancer’s substantial health, social, developmental and financial burden, recognising that behavioural and environmental factors account for an estimated 80–90% of cases and that at least 30% may be preventable through integrated interventions.
Key quantified ambitions include detecting priority tumours early within five years and reducing mortality from these tumours by about 20% within ten years.Primary-prevention ambitions include reducing adult tobacco use by 5% over ten years, reducing overweight and obesity by at least 10%, increasing physical activity by at least 20%, and doubling the proportion of ex-smokers within ten years.Breast-cancer objectives prioritise treatable and curable disease, with long-term mortality reductions of 25–30% for women aged 50–69 and 15% for women aged 40–49.
Implement the programme through national coordination, cross-sectoral prevention, integrated service delivery, workforce development, standardised protocols, referral systems, information systems and periodic performance review.The approach requires government commitment, prioritisation and resource allocation, while engaging Ministry of Health departments, specialist cancer centres, hospitals, primary care centres, universities, non-governmental organisations, relevant government bodies, private-sector actors and health decision-makers.
Monitoring combines baseline surveys, routine data systems, cancer registries, data-quality checks and annual performance assessment.Indicators include registration completeness and accuracy, survival for common cancers, service-quality measures, research completion, patient satisfaction, participation in care, home-care delivery and joint community activities.Breast-screening monitoring covers mammography coverage, response, stage distribution, referral, treatment and mortality, with a target of 75% coverage every three years and a goal to reduce stage 3 and 4 diagnoses to 20%.
Financial governance includes budget allocation for the main programme and sub-programmes, identification of funding sources, charitable contributions, financial rules and resource allocation.Government financial support is envisaged for palliative-care integration and service resources, and approved cancer research studies require budget monitoring.No quantified overall budget, funding allocation, funding gap or cost-effectiveness analysis is specified.
The plan establishes a broad monitoring and evaluation agenda centred on cancer surveillance, early detection, service quality, prevention outcomes, research performance and community participation. It calls for strengthened national and Gulf cancer registries, routine institutional data collection, data-quality checks, survival analysis and a comprehensive database for programme evaluation.It also requires periodic programme evaluation, weekly and monthly supervision and follow-up timetables, and annual assessment of cancer-control performance.
Early detection is monitored through tumour-specific coverage, diagnostic and treatment measures. For breast cancer, the plan proposes monitoring mammography coverage, screening response, early detection, stage distribution, referral and treatment after abnormal mammograms, and mortality.It targets 75% mammography coverage of the target group every three years, reduction of stage 3 and 4 diagnoses to 20%, specialist diagnosis and urgent treatment for all women with abnormal mammograms, reduction of advanced disease at diagnosis to 10%, and mortality reduction of at least 25% after ten years.Elsewhere, the plan seeks early detection of breast, cervical, colorectal, oral and skin cancers within five years and approximately 20% lower mortality from these tumours within ten years.
Prevention monitoring covers tobacco, diet, physical activity, obesity, infections and carcinogenic exposures. Indicators include adult tobacco use and tobacco use among 13 to 15-year-olds through the Global Youth Tobacco Survey, overweight and obesity, central obesity, physical activity, fruit and vegetable consumption, tobacco-free indoor places, cancer-causing infections, and environmental and occupational exposures.The plan defines overweight as a body mass index of 25 to 29.9 kg/m² and obesity as a body mass index of at least 30 kg/m².It also specifies waist-to-hip ratio thresholds of 0.85 for men and 0.95 for women, and waist-circumference thresholds of 94 cm for men and 80 cm for women.
Service-quality monitoring includes the proportion of patients seen in primary care, specialist staffing against international rates, annual training coverage, availability of evidence-based guidance, cancer units and specialised centres, and alignment of services with relevant guidance.Palliative-care planning includes assessing the number of people needing care using cancer deaths, identifying patient and family needs and service gaps, establishing standards, and evaluating implemented activities.The plan also measures patient satisfaction, patient and family involvement in treatment control, education and home-care programmes, community-care nurses, social workers, patient adherence, completed research studies, and joint programmes involving community institutions.
Accountability mechanisms include a Supreme National Cancer Control Committee, programme supervision, financial oversight, resource allocation, periodic evaluation and coordination across implementing agencies.However, the available text does not specify a consolidated reporting schedule, named data custodians, audit procedures, formal accountability sanctions or a complete indicator framework with targets for every area.
Financing provisions are largely institutional rather than quantified. The administrative programme is expected to allocate budgets for the main programme and sub-programmes, identify funding sources, address charitable contributions, establish financial rules, supervise financial matters and allocate resources.Government financial support is also envisaged for integrating palliative care into the national health system and securing the resources required for palliative services.
No numeric budget, expenditure ceiling, unit cost, funding allocation, financing source, resource-mobilisation target, funding gap, cost-effectiveness analysis or other economic assumption is specified in the available text.